Instead of building its own network of providers and bringing hybrid care services to employers like it did with Amazon Care, the new Amazon Clinic model is direct-to-consumer and outsources to third-party providers. It will likely be the more successful route for the retailer, after failing with Haven and Amazon Care, experts said.
Phone calls account for 70% of people's first point of contact with a health system, so hospitals have sought to implement software that balances the need for speedy automation with intelligent systems that anticipate and best serve patient and care giver needs.
INVEST 2023 will unite innovative startups, active investors as well as forward-thinking healthcare providers, payers and life science companies. Join us for exclusive networking opportunities and engaging content that highlights the opportunities and challenges the industry faces as it continues to evolve.
By Frank Vinluan Sunday, November 20, 2022 12:01 PM
Eli Lilly's stalled cancer drug prexasertib has another chance under Acrivon Therapeutics, whose IPO will fund a fresh slate of mid-stage clinical trials. While attention is focused on the former Lilly asset, also at stake is Acrivon's technology platform that relies on proteomics rather than genomics for identifying patients appropriate for targeted therapies.
By Marissa Plescia Sunday, November 20, 2022 11:30 AM
When asked if they had heard about their state returning to Medicaid renewals once the public health emergency ends, 62% said they haven't heard anything, a new report found. Only 5% said they've heard a lot about it.
By Ben El-Chami Sunday, November 20, 2022 10:00 AM
For far too long, dentists have focused on drilling and billing rather than optimizing the patient experience — and that's driving many of our patients away, with terrible results for their dental health.
There are currently 97 global digital health companies that are considered unicorns. But getting caught up with the idea of digital health unicorns isn't very sustainable, according to Emilly Melton, managing partner at Threshold Ventures. Instead of focusing too much on their valuations, she recommended that startups simply focus on getting the capital they need in order to reach the next stage of inflection.
By Arundhati Parmar Sunday, November 20, 2022 9:01 AM
MedCity News interviews CEOs of public companies, entrepreneurs, VCs and payers who had a range of varying answers to the question. But one common theme emerged: everyone, currently, has a vise-like grip on expenditure.
Today, the pharmaceutical industry is undergoing a rapid and dynamic transformation. Successful contract management plays an instrumental role in navigating this landscape.
No comments